BIO-key International (NASDAQ:BKYI) Share Price Passes Below 200-Day Moving Average – What’s Next?

BIO-key International Inc. (NASDAQ:BKYI) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $5.67 and traded as low as $4.50. BIO-key International shares last traded at $4.60, with a volume of 4,446 shares.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a report on Monday, April 20th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, BIO-key International presently has a consensus rating of “Sell”.

BIO-key International Trading Up 4.5%

The firm has a market capitalization of $4.99 million, a P/E ratio of -0.66 and a beta of 0.44. The company has a quick ratio of 1.13, a current ratio of 1.26 and a debt-to-equity ratio of 0.17. The firm has a 50 day moving average of $4.72 and a 200-day moving average of $5.67.

BIO-key International (NASDAQ:BKYI) last released its earnings results on Tuesday, March 31st. The technology company reported ($0.19) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.70) by $0.51. The firm had revenue of $1.24 million during the quarter, compared to the consensus estimate of $2.20 million. BIO-key International had a negative return on equity of 67.43% and a negative net margin of 75.32%.

Institutional Trading of BIO-key International

An institutional investor recently raised its stake in BIO-key International stock. Geode Capital Management LLC raised its stake in BIO-key International Inc. (NASDAQ:BKYI) by 49.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 48,892 shares of the technology company’s stock after acquiring an additional 16,271 shares during the quarter. Geode Capital Management LLC owned approximately 0.45% of BIO-key International worth $26,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 26.51% of the company’s stock.

BIO-key International Company Profile

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.